Docoh
Loading...

MYGN Myriad Genetics

APP
Utility
Hereditary Cancer Genes
11 Nov 21
The invention generally relates to a molecular classification of disease predisposition and particularly to molecular markers for cancer predisposition and methods of use thereof.
Kirsten Timms, Brian Allen, Anne-Renee Hartman
Filed: 22 Jul 21
APP
Utility
Methods and Materials for Assessing Homologous Recombination Deficiency
7 Oct 21
This document provides methods and materials involved in assessing samples (e.g., cancer cells) for the presence of homologous recombination deficiency (HRD) or an HRD signature.
Victor Abkevich, Kirsten Timms, Alexander Gutin
Filed: 21 Jun 21
APP
Utility
Methods and Systems for Somatic Mutations and Uses Thereof
26 Aug 21
This invention provides methods and compositions for detecting somatic mutations in cancer cells.
Andrey ZHARKIKH, Kirsten TIMMS, Michael PERRY, Alexander GUTIN
Filed: 6 May 21
APP
Utility
Gene Signatures for Cancer Prognosis
11 Mar 21
Biomarkers and methods using the biomarkers for classifying cancer in a patient (e.g., predicting the risk of cancer-specific death or cancer recurrence) are provided.
Steven Stone, Alexander Gutin, Susanne Wagner, Julia Reid
Filed: 12 Nov 20
APP
Utility
Methods and Materials for Assessing Loss of Heterozygosity
23 Dec 20
This document provides methods and materials involved in assessing samples (e.g., cancer cells) for the presence of a loss of heterozygosity (LOH) signature.
Victor Abkevich, Alexander Gutin, Kirsten Timms, Jerry Lanchbury
Filed: 3 Sep 20
APP
Utility
Method of Using Biomarkers and Clinical Variables for Predicting Chemotherapy Benefit
9 Sep 20
Provided herein are methods for predicting chemotherapy benefit.
Alexander GUTIN, Julia REID, Ralf KRONENWETT, Marsel SCHEER
Filed: 3 Mar 20
APP
Utility
Genes and Gene Signatures for Diagnosis and Treatment of Melanoma
12 Aug 20
Panels of biomarkers, methods and systems are disclosed for determining gene expression, and diagnosing and treating melanoma.
Michael Bryan WARF, Benjamin ROA, Alexander GUTIN, Darl FLAKE
Filed: 9 Feb 20
APP
Utility
Adjusted Multi-biomarker Disease Activity Score for Inflammatory Disease Assessment
5 Aug 20
Provided herein are methods for assessing response to inflammatory disease therapy.
Ching Chang HWANG, David CHERNOFF, Alexander GUTIN, Darl FLAKE, Jerry LANCHBURY, Paul Scott EASTMAN, Eric SASSO
Filed: 29 Jul 18
APP
Utility
Methods and Materials for Assessing Allelic Imbalance
29 Jul 20
Methods and systems for detecting allelic imbalance using nucleic acid sequencing are provided.
Alexander Gutin, Kirsten Timms, Jerry Lanchbury
Filed: 10 Mar 20
APP
Utility
Methods and Materials for Assessing Loss of Heterozygosity
17 Jun 20
This document provides methods and materials involved in assessing samples (e.g., cancer cells) for the presence of a loss of heterozygosity (LOH) signature.
Victor Abkevich, Alexander Gutin, Kirsten Timms, Jerry Lanchbury
Filed: 23 Feb 20
APP
Utility
Methods and Materials for Assessing Loss of Heterozygosity
18 Mar 20
This document provides methods and materials involved in assessing samples (e.g., cancer cells) for the presence of a loss of heterozygosity (LOH) signature.
Victor Abkevich, Alexander Gutin, Kirsten Timms, Jerry Lanchbury
Filed: 20 Nov 19
APP
Utility
Cancer Biomarkers
19 Feb 20
Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
Steven STONE, Alexander GUTIN, Susanne WAGNER, Julia REID
Filed: 24 Oct 19
APP
Utility
Methods and Materials for Assessing Loss of Heterozygosity
8 Jan 20
This document provides methods and materials involved in assessing samples (e.g., cancer cells) for the presence of a loss of heterozygosity (LOH) signature.
Victor Abkevich, Alexander Gutin, Kirsten Timms, Jerry Lanchbury
Filed: 18 Sep 19
  • 1
Patents are sorted by USPTO publication date, most recent first